Adipose stem cell heart attack trial data published in JACC

Cytori announced the publication of previously reported six-month outcomes from APOLLO, the Company's European clinical trial evaluating adipose-derived stem and regenerative cells (ADRCs) in patients with acute myocardial infarction, as Research Correspondence in the Journal of the American College of Cardiology. The APOLLO trial was a 14-patient, prospective, randomized, double-blind, placebo-controlled, feasibility trial evaluating autologous ADRCs extracted with the proprietary Celution System for the treatment of patients suffering from acute myocardial infarction. Read more